PMV PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

PMV PHARMACEUTICALS INC share price today is $1.46, up -2%. The stock opened at $1.49 against the previous close of $1.5, with an intraday high of $1.51 and low of $1.465.

PMV PHARMACEUTICALS INC Share Price Chart

PMV PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
us-stock

PMV PHARMACEUTICALS INC Share Price Performance

$1.46 -0.02(-2%) PMVP at 23 Mar 2026 02:48 PM Biotechnology
Lowest Today 1.465
Highest Today 1.51
Today’s Open 1.49
Prev. Close 1.5
52 Week High 1.88
52 Week Low 0.81
Day’s Range: Low 1.465 High 1.51
52-Week Range: Low 0.81 High 1.88
1 day return -
1 Week return -4.45
1 month return +45.63
3 month return +19.52
6 month return +13.2
1 year return +21.95
3 year return -69.75
5 year return -96.46
10 year return -

PMV PHARMACEUTICALS INC Institutional Holdings

BML Capital Management LLC 9.92

Orbimed Advisors, LLC 9.33

TANG CAPITAL MANAGEMENT LLC 8.97

ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 5.79

Sio Capital Management, LLC 4.94

Euclidean Capital LLC 4.93

Vanguard Group Inc 4.07

Acadian Asset Management LLC 3.87

Vanguard Total Stock Mkt Idx Inv 2.79

ArrowMark Small Cap Gro 2.34

Meridian Small Cap Growth Legacy 2.34

Stonepine Capital Management Llc 2.16

BlackRock Inc 2.07

Two Sigma Advisers, LLC 1.64

Two Sigma Investments LLC 1.32

Jacobs Levy Equity Management, Inc. 0.98

Jane Street Group LLC 0.94

Aldebaran Capital LLC 0.90

Marshall Wace Asset Management Ltd 0.87

Geode Capital Management, LLC 0.84

Bridgeway Capital Management, LLC 0.80

Vanguard Institutional Extnd Mkt Idx Tr 0.77

Northern Trust Corp 0.71

Walleye Trading Advisors, LLC 0.63

Bridgeway Ultra-Small Company 0.62

Fidelity Extended Market Index 0.41

iShares Micro-Cap ETF 0.22

Blackrock Extended Mkt Fund CF 0.19

Extended Equity Market Fund K 0.16

Goldman Sachs Absolute Ret Trckr Instl 0.15

Bridgeway Ultra-Small Company Market 0.14

Fidelity Total Market Index 0.13

Invesco Technology S&P US Sel Sec ETF 0.13

Nationwide Bailard Sm Cp Val M 0.12

Fidelity Series Total Market Index 0.11

Spartan Extended Market Index Pool F 0.10

Multi-Manager Small Cap Eq Strat Inst 0.10

Northern Trust Extended Eq Market Idx 0.09

NT Ext Equity Mkt Idx Fd - L 0.09

NT Ext Equity Mkt Idx Fd - NL 0.09

PMV PHARMACEUTICALS INC Market Status

Strong Buy: 4

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

PMV PHARMACEUTICALS INC Fundamentals

Market Cap 78.39 M

PB Ratio 0.7614

PE Ratio 0.0

Enterprise Value -32.11 M

Total Assets 116.56 M

Volume 283951

PMV PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-72549000 -72.5M, FY22:-73317000 -73.3M, FY21:-57846000 -57.8M, FY20:-34440000 -34.4M, FY19:-25352000 -25.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-32000 -0.0M, Q2/2025:-32000 -0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-372000 -0.4M

Quarterly Net worth Q3/2025:-21059000 -21.1M, Q2/2025:-21210000 -21.2M, Q1/2025:-17436000 -17.4M, Q3/2024:-19226000 -19.2M, Q2/2024:-1213000 -1.2M

About PMV PHARMACEUTICALS INC & investment objective

Company Information PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Organisation Biotechnology

Employees 54

Industry Biotechnology

CEO Dr. David H. Mack Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

PMV PHARMACEUTICALS INC FAQs

What is the share price of PMV PHARMACEUTICALS INC today?

The current share price of PMV PHARMACEUTICALS INC is $1.46.

Can I buy PMV PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy PMV PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy PMV PHARMACEUTICALS INC shares in India?

You can easily invest in PMV PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of PMV PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of PMV PHARMACEUTICALS INC?

PMV PHARMACEUTICALS INC has a market cap of $78.39 M.

In which sector does PMV PHARMACEUTICALS INC belong?

PMV PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in PMV PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of PMV PHARMACEUTICALS INC?

The PE ratio of PMV PHARMACEUTICALS INC is N/A and the PB ratio is 0.76.